Farwits’ R & D team is categorized into two groups, basic scientific research team and processing research team. The former is mainly constituted with prominent returned scientists and projects pioneers, who have undertaken deep research and achieved abundant fruits in the field of recombinant vaccines, recombinant antigens for disease diagnosis, etc. They are holding powerful scientific research basis and technical advantages in Escherichia Coli expression, Yeast expression, Baculovirus expression, especially adenovirus vector vaccines.

The latter is made up of many specialists and technicians who have rich experience in industrial transformation of biopharma. They process nationally advanced innovative development ability in large-scale fermentation, animal cells bioreactor culture, separation and purification of biomacromolecules, stem cells culture and so on.Besides, Farwits founded a united laboratory, called “Sichuan Provincial Novel Technology Research & Transformation Center of Biopharma” together with Sichuan Academy of Medical Science, which integrates all merits of two parties to perform bilateral functions on this platform.